The International Pharmacopoeia is a collection of recommended procedures for analysis and specifications for active pharmaceutical ingredients, excipients and finished pharmaceutical products. It serves WHO Member States wishing to establish pharmaceutical requirements as source material for reference or adaptation.
The International Pharmacopoeia focuses on monographs of particular relevance to low- and middle-income countries which may not have sufficient resources to develop national pharmacopoeias. Our compendium supports key WHO activities, such as the Organization's efforts to make essential medicines available and affordable for everyone, everywhere and to combat substandard and falsified medicines.
- Numerous new and revised texts have been introduced in the 11th Edition, including for example:
- Albendazole chewable tablets
- Dolutegravir (dispersible) tablets
- Dolutegravir, lamivudine and tenofovir disoproxil tablets
- Lamivudine oral solutions
- Norethisterone enantate injection
- Remdesivir intravenous infusion
- Tenofovir disoproxil fumarate
- Ulipristal acetate tablets